欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2002, Vol. 7 ›› Issue (6): 544-545.

• 研究原著 • 上一篇    下一篇

米力农治疗慢性充血性心力衰竭疗效评价

李挺   

  1. 广东省肇庆市第一人民医院心内科,肇庆 526021
  • 收稿日期:2002-03-04 修回日期:2002-06-20 出版日期:2002-12-26 发布日期:2020-11-20
  • 通讯作者: 李挺,男,副主任医师。Tel:0758-2860604

Evaluation of the efficacy of milrinone in treatment of chronic congestive heart failure

LI Ting   

  1. Department of Cardiology,First People' s Hospital of Zhaojing City,Zhaojing,Guangdong 526021
  • Received:2002-03-04 Revised:2002-06-20 Online:2002-12-26 Published:2020-11-20

摘要: 目的 探讨米力农治疗慢性充血性心力衰竭的疗效。方法 将122 例不同病因的慢性充血性心力衰竭患者随机分为两组,米力农组66 例,使用米力农治疗,10 mg·d-1,连用5 d;多巴酚丁胺组使用多巴酚丁胺治疗,160 mg·d-1,连用5 d 。结果 米力农组心功能改善总有效率为93.9%,优于多巴酚丁胺组56 例(76.7%),差异具有显著性意义,且心率明显减慢,而血压则无明显变化。结论 米力农治疗慢性充血性心力衰竭疗效肯定。

关键词: 米力农, 慢性充血性心力衰竭, 多巴酚丁胺

Abstract: AIM: To estimate the efficacy of milrnone in treatment of congestive heart failure.METHODS: 122 cases of chronic congestive heart failure with different etiology were divided into milrinone groupand dabutamine grouprandomly.Milrinone groupaccepted milrinone(10mg·d-1)for 5 days,and dabutamine groupaccepted dabutamine(160 mg ·d-1)for 5 days.The efficacy of treatments was evaluated.RESULTS: The effectiveness rates of cardiac function improvement were 93.9% and76.7% in milrinone groupand dabutamine group,respectively(p<0.05).The cardiac function improvement accompanied by the heart rate decrease and stable blood pressure in milrinone group.CONCLUSION: Milrinone is an effective drug for chronic congestive heart failure.

Key words: milrnone, chronic congestive heart failure, dabutamine

中图分类号: